REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 57.00
Ask: 58.00
Change: -0.20 (-0.35%)
Spread: 1.00 (1.754%)
Open: 57.70
High: 0.00
Low: 0.00
Prev. Close: 57.70
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Employee Share Participation Plan

4 Feb 2020 15:46

RNS Number : 9552B
Accsys Technologies PLC
04 February 2020
 

AIM: AXS

Euronext Amsterdam: AXS

 

4 February 2020

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Accsys Employee Share Participation Plan

 

Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create high performance, sustainable wood building products, announces the issue of new ordinary shares of €0.05 each in the Company ("Shares") to employees in relation to employee incentivisation and share plan arrangements.

The Company previously established an Employee Share Participation Plan (the "Plan") intended to promote the long term growth and profitability of Accsys by providing employees with an opportunity to acquire an ownership interest in Shares as an additional benefit of employment. Under the terms of the Plan, the Company issues Shares to a trust for the benefit of the subscribing employees with the Shares to be released to employees after one year, together with an additional Share on a 1 for 1 matched basis provided the employee remains in the employment of Accsys at that point in time (the "Matching Shares").

Pursuant to the terms of the Plan, various employees have subscribed for a total of 204,612 Shares at an acquisition price of €1.095 per Share, being the closing price of Shares in the Company on 12 December 2019 on Euronext Amsterdam, the closing date for subscriptions under the Plan.

The Shares in the Company will be issued pending admission to trading on AIM and Euronext which is expected to take place on 5 February 2020 ("Admission").

The total number of issued Shares following Admission will be 162,288,155 Shares. The Company does not hold any shares in treasury. Therefore, the total voting rights in the Company following Admission will be 162,288,155. This figure may be used by shareholders as the denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company's securities under the FCA's Disclosure Guidance and Transparency Rules.

Ends

For further information, please contact:

Accsys Technologies PLC

Robert Harris, CEO

William Rudge, FD

 

via FTI Consulting

Numis Securities Limited -Nominated Adviser and

Joint Broker

Oliver Hardy (NOMAD)

Ben Stoop

Oliver Cox

 

+44 (0) 20 7260 1000

 

 

Investec Bank plc - Joint Broker

 

Carlton Nelson

James Rudd

Alex Wright

 

 

+44 (0) 20 7597 5970

FTI Consulting

Matthew O'Keeffe

Alex Le May

 

+44 (0) 20 3727 1340

 

Off the Grid (The Netherlands)

Frank Neervoort

Giedo Van Der Zwan

+31 681 734 236

+31 624 212 238

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Tricoya® Consortium In March 2017, Accsys announced the formation of the Tricoya® Consortium to fund, build and operate the Tricoya® plant in Hull, UK. Members of the consortium include BP and the leading manufacturer of sustainable wood-based panels, MEDITE Europe DAC. Tricoya Ventures UK Ltd (TVUK), a subsidiary of Accsys, owns and will operate the Tricoya® plant. TTL exploits all Tricoya® related intellectual property and benefits from any Tricoya® related revenues other than those generated by the Tricoya® plant. The Tricoya® plant is expected to have an initial capacity of 30,000 metric tonnes of Tricoya® chips per annum, enough to produce approximately 40,000m3 of Tricoya® panel products per annum. The Tricoya® plant is expected to reach EBITDA breakeven at approximately 40% design capacity and to take approximately four years to reach full capacity following completion. The location of the Tricoya® plant at Saltend Chemicals Park in Hull allows for expansion when market conditions dictate.

 

Accoya®Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

'Accsys' and 'AccsysTechnologies'aretrading names of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKQBQPBKDBBK
Date   Source Headline
28th Sep 20124:28 pmRNSTotal Voting Rights
14th Sep 20127:02 amRNSResult of AGM
31st Aug 20124:30 pmRNSTotal Voting Rights
29th Aug 20127:00 amRNSNotice of AGM
17th Aug 20124:27 pmRNSAccsys Employee Share Participation Plan
9th Aug 20127:01 amRNSInterim Management Statement
3rd Aug 20127:02 amRNSEmployee Share Participation Plan and Grant of Opt
27th Jul 20124:30 pmRNSTotal Voting Rights
24th Jul 20127:02 amRNSHeads of Terms with INEOS for joint venture
13th Jul 20129:18 amRNSDirector/PDMR Shareholding
11th Jul 20124:40 pmRNSSecond Price Monitoring Extn
11th Jul 20124:35 pmRNSPrice Monitoring Extension
10th Jul 20127:00 amRNSAnnual Results
5th Jul 20124:16 pmRNSDirectors' Interests
5th Jul 20129:02 amRNSAnnual results release date and webcast
2nd Jul 20127:02 amRNSAccoya® Licence Agreement with Solvay-Rhodia
30th Apr 20127:04 amRNSLicence Option Agreeement
29th Mar 20124:49 pmRNSNotifiable Interest
15th Mar 20125:24 pmRNSDirector/PDMR Shareholding
6th Mar 201210:21 amRNSBP Strategic Relationship
22nd Feb 20122:10 pmRNSTotal Voting Rights
21st Feb 20123:38 pmRNSNotifiable Interest
17th Feb 20127:01 amRNSInterim Management Statement
10th Feb 20124:35 pmRNSPrice Monitoring Extension
7th Feb 20124:52 pmRNSDirector Shareholding
7th Feb 201210:41 amRNSNotifiable Interest
27th Jan 20129:46 amRNSAnnual Information Update
24th Jan 201210:11 amRNSNotifiable Interest
18th Jan 20124:40 pmRNSSecond Price Monitoring Extn
18th Jan 20124:35 pmRNSPrice Monitoring Extension
16th Jan 20124:40 pmRNSSecond Price Monitoring Extn
16th Jan 20124:35 pmRNSPrice Monitoring Extension
3rd Jan 20122:08 pmRNSDirector/PDMR Shareholding
30th Dec 201112:40 pmRNSSecond Price Monitoring Extn
30th Dec 201112:35 pmRNSPrice Monitoring Extension
20th Dec 20114:40 pmRNSDirector/PDMR Shareholding
16th Dec 20113:34 pmRNSNotifiable Interest
9th Dec 20114:35 pmRNSPrice Monitoring Extension
6th Dec 20119:24 amRNSNotifiable Interest
30th Nov 20117:12 amRNSSeptember 2011 Interim Financial Statement
25th Nov 201112:22 pmRNSInterim results release date and webcast
2nd Nov 20114:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20114:35 pmRNSPrice Monitoring Extension
21st Oct 20118:28 amRNSAppointment of Nominated Advisor and broker
8th Sep 20113:25 pmRNSResult of AGM
31st Aug 20119:05 amRNSTotal Voting Rights
10th Aug 20117:01 amRNSInterim Management Statement
4th Aug 20114:40 pmRNSSecond Price Monitoring Extn
4th Aug 20114:35 pmRNSPrice Monitoring Extension
1st Aug 201111:42 amRNSEmployee Share Plan and Grant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.